Evidence map›Paper›PMID 36800554›Full record

ArticleDiabetes care2023

A National Physician Survey of Deintensifying Diabetes Medications for Older Adults With Type 2 Diabetes.

Scott J Pilla, Rabia Jalalzai, Olive Tang, Nancy L Schoenborn, Cynthia M Boyd, Sherita H Golden, Nestoras N Mathioudakis, Nisa M Maruthur

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes care, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Observational
  2. [Clinical and molecular characteristics of neonatalZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A National Physician Survey Examining Switching From Sulfonylureas or Insulin to Newer Diabetes Medications.Clinical diabetes : a publication of the American Diabetes Association · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Scott J PillaDivision of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0000-0002-3292-9047
Rabia JalalzaiDivision of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Olive TangDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.
Nancy L SchoenbornDivision of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Cynthia M BoydDepartment of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.
Sherita H GoldenDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Nestoras N MathioudakisDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Nisa M MaruthurDivision of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Johns Hopkins University · US

Funding

U.S. Deprescribing Research NetworkR24AG064025 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI CYNTHIA Melinda BOYD, MICHAEL A. STEINMAN · 2023 to 2023
$3.8M
Medical Scientist Training ProgramT32GM136577 · JOHNS HOPKINS UNIVERSITY · 2025 to 2025
$2.0M
Effectiveness of Digital Versus In-Person Diabetes Prevention ProgramsR01DK125780 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI NESTORAS N MATHIOUDAKIS · 2023 to 2023
$704k
NCATS NIH HHS KL2 TR003099NIA NIH HHS K24 AG056578NIA NIH HHS K76 AG059984NIA NIH HHS R24 AG064025NIDDK NIH HHS K23 DK128572NIDDK NIH HHS R01 DK125780NIGMS NIH HHS T32 GM136577
6 · The paper itself

Abstract

objectiveTo determine physicians' approach to deintensifying (reducing/stopping) or switching hypoglycemia-causing medications for older adults with type 2 diabetes. RESEARCH DESIGN AND

methodsIn this national survey, U.S. physicians in general medicine, geriatrics, or endocrinology reported changes they would make to hypoglycemia-causing medications for older adults in three scenarios: good health, HbA1c of 6.3%; complex health, HbA1c of 7.3%; and poor health, HbA1c of 7.7%.

resultsThere were 445 eligible respondents (response rate 37.5%). In patient scenarios, 48%, 4%, and 20% of physicians deintensified hypoglycemia-causing medications for patients with good, complex, and poor health, respectively. Overall, 17% of physicians switched medications without significant differences by patient health. One-half of physicians selected HbA1c targets below guideline recommendations for older adults with complex or poor health.

conclusionsMost U.S. physicians would not deintensify or switch hypoglycemia-causing medications within guideline-recommended HbA1c targets. Physician preference for lower HbA1c targets than guidelines needs to be addressed to optimize deintensification decisions.

Indexed as

Diabetes Mellitus, Type 2HypoglycemiaPhysiciansAgedBlood GlucoseGlycated HemoglobinHumansHypoglycemic AgentsBlood GlucoseGlycated HemoglobinHypoglycemic Agents

Identifiers

PMID36800554
PMCPMC10234750
OpenAlexW4321183786

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.